Call for Abstract
2nd International Conference on Parkinsons and Neurodegenerative Diseases, will be organized around the theme “Essential Innovations and Developments in treatment of Parkinsons and Neurodegenerative Diseases”
Parkinsons-2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Parkinsons-2021
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Parkinson’s disease (PD) is a chronic and progressive disease of nervous system that possesses symptoms which continue and become worse over time. It is the second commonest neurodegenerative disease after Alzheimer's disease, and in the UK, has a lifetime prevalence of between 0.1 and 0.3% of the population. The basic reason behind this condition is malfunction and death of vital nerve cells in brain. In normal conditions nerve cells present in the brain produces a neurotransmitter called dopamine that is responsible for signalling movement, emotions and co-ordination but in the case of diseased individual dopamine production slows down, hence the individual become unable to control the movement normally. There is no cure but treatment involves medication and surgery. Slowness of voluntary movements, reduced facial appearance, repetitious tongue, and diminished eye flashing, A shuffling gait with deprived arm swing and curved posture, Shaky stability; difficulty rising from a sitting position, Swallowing problems in later stages.
Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells to die. Alzheimer's disease is the most common cause of dementia, and is characterized by a gradual loss of thinking, mental, and social skills that impairs an individual's ability to function independently. The disease's early symptoms include forgetting recent events or conversations. As Alzheimer's disease progresses, a person may experience severe memory loss and lose the ability to perform daily tasks. Medications can temporarily improve or postpone the progression of symptoms. Alzheimer's disease patients and their families will benefit from a number of programmes and services. Moods and habits may be influenced by Alzheimer's disease-related brain changes. The following are examples of possible issues: Depression, social isolation, sleep disturbances, loss of inhibitions, delusions, and other symptoms can occur.
Multiple sclerosis (MS) is a central nervous system condition that can be debilitating (brain and spinal cord). The immune system attacks the protective sheath (myelin) that covers nerve fibres in MS, causing communication problems with your brain and the rest of your body. The disease can cause irreversible nerve damage or weakening in the long run. MS signs and symptoms vary significantly depending on the degree of nerve damage and which nerves are damaged. Some people with severe MS may lose their ability to walk independently or at all, while those with no new symptoms may go into remission for long periods of time. The signs and symptoms of multiple sclerosis can differ significantly from person to person and over the course of the disease, depending on where the affected nerve fibres are located. Symptoms such as numbness or stiffness in one or more joints, which typically happens on one side of the body or in the legs and trunk at the same time, may often affect movement. Electric shock sensations that occur when such movements are made of neck, especially bending the neck forward, Tremor, absence of coordination.
The study of the structure and function of the nervous system is known as Neuroanatomy. In contrast to radial symmetry animals, which have a distributed cell network in their nervous systems, bilateral symmetry animals have segregated, formed nervous systems. In vertebrates, the nervous system is divided into two parts: the inner structure of the brain and spinal cord (commonly referred to as the CNS) and the nerve pathways that connect to the rest of the body (known as the peripheral nervous system, or PNS).
Neuroplasticity, which encompasses both synaptic and non-synaptic plasticity, is often referred to as brain plasticity or neural plasticity, and refers to improvements in neural pathways and synapses as a result of changes in behaviour, environment, neural processes, thought, and emotions, as well as changes in the body. The aim of this session is to learn about the latest advances in brain plasticity as it relates to neurite remodelling and how to improve neural connections. Neurorehabilitation is a therapeutic method that aims to aid recovery from nervous system damage while also minimising or compensating for any functional changes that result.